Your browser doesn't support javascript.
loading
TRIM28 and Interacting KRAB-ZNFs Control Self-Renewal of Human Pluripotent Stem Cells through Epigenetic Repression of Pro-differentiation Genes.
Oleksiewicz, Urszula; Gladych, Marta; Raman, Ayush T; Heyn, Holger; Mereu, Elisabetta; Chlebanowska, Paula; Andrzejewska, Anastazja; Sozanska, Barbara; Samant, Neha; Fak, Katarzyna; Auguscik, Paulina; Kosinski, Marcin; Wróblewska, Joanna P; Tomczak, Katarzyna; Kulcenty, Katarzyna; Ploski, Rafal; Biecek, Przemyslaw; Esteller, Manel; Shah, Parantu K; Rai, Kunal; Wiznerowicz, Maciej.
Afiliación
  • Oleksiewicz U; Laboratory for Gene Therapy, Department of Cancer Immunology, Poznan University of Medical Sciences, 60-806 Poznan, Poland; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
  • Gladych M; Laboratory for Gene Therapy, Department of Cancer Immunology, Poznan University of Medical Sciences, 60-806 Poznan, Poland; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
  • Raman AT; Graduate Program in Structural and Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Heyn H; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona 08908, Catalonia, Spain; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08036, Spain; Universitat Pom
  • Mereu E; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08036, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Chlebanowska P; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland; University of Life Sciences, 60-637 Poznan, Poland.
  • Andrzejewska A; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland; Adam Mickiewicz University, Biology Department, 61-614 Poznan, Poland.
  • Sozanska B; Faculty of Mathematics and Information Science, Warsaw University of Technology, 00-602 Warsaw, Poland.
  • Samant N; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Fak K; Faculty of Mathematics and Information Science, Warsaw University of Technology, 00-602 Warsaw, Poland.
  • Auguscik P; Faculty of Mathematics and Information Science, Warsaw University of Technology, 00-602 Warsaw, Poland.
  • Kosinski M; Faculty of Mathematics and Information Science, Warsaw University of Technology, 00-602 Warsaw, Poland.
  • Wróblewska JP; Laboratory for Gene Therapy, Department of Cancer Immunology, Poznan University of Medical Sciences, 60-806 Poznan, Poland; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
  • Tomczak K; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland; Postgraduate School of Molecular Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Kulcenty K; Laboratory for Gene Therapy, Department of Cancer Immunology, Poznan University of Medical Sciences, 60-806 Poznan, Poland; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
  • Ploski R; Department of Medical Genetics, Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Biecek P; Faculty of Mathematics and Information Science, Warsaw University of Technology, 00-602 Warsaw, Poland; Warsaw Faculty of Mathematics, Informatics, and Mechanics, University of Warsaw, 02-097 Warsaw, Poland.
  • Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona 08908, Catalonia, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona 08907, Catalonia, Spain;
  • Shah PK; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Rai K; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. Electronic address: krai@mdanderson.org.
  • Wiznerowicz M; Laboratory for Gene Therapy, Department of Cancer Immunology, Poznan University of Medical Sciences, 60-806 Poznan, Poland; Laboratory for Gene Therapy, Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland. Electronic address: wiznerowicz@ump.edu.pl.
Stem Cell Reports ; 9(6): 2065-2080, 2017 12 12.
Article en En | MEDLINE | ID: mdl-29198826
ABSTRACT
Reprogramming to induced pluripotent stem cells (iPSCs) and differentiation of pluripotent stem cells (PSCs) are regulated by epigenetic machinery. Tripartite motif protein 28 (TRIM28), a universal mediator of Krüppel-associated box domain zinc fingers (KRAB-ZNFs), is known to regulate both processes; however, the exact mechanism and identity of participating KRAB-ZNF genes remain unknown. Here, using a reporter system, we show that TRIM28/KRAB-ZNFs alter DNA methylation patterns in addition to H3K9me3 to cause stable gene repression during reprogramming. Using several expression datasets, we identified KRAB-ZNFs (ZNF114, ZNF483, ZNF589) in the human genome that maintain pluripotency. Moreover, we identified target genes repressed by these KRAB-ZNFs. Mechanistically, we demonstrated that these KRAB-ZNFs directly alter gene expression of important developmental genes by modulating H3K9me3 and DNA methylation of their promoters. In summary, TRIM28 employs KRAB-ZNFs to evoke epigenetic silencing of its target differentiation genes via H3K9me3 and DNA methylation.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Represoras / Diferenciación Celular / Células Madre Pluripotentes / Proteína 28 que Contiene Motivos Tripartito Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Reports Año: 2017 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Represoras / Diferenciación Celular / Células Madre Pluripotentes / Proteína 28 que Contiene Motivos Tripartito Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Reports Año: 2017 Tipo del documento: Article País de afiliación: Polonia